60 Degrees Pharmaceuticals shares are trading higher after the company announced that it granted the University of Kentucky a right of reference to its new drug application for ARAKODA.
Portfolio Pulse from Benzinga Newsdesk
60 Degrees Pharmaceuticals shares are trading higher after the company announced that it granted the University of Kentucky a right of reference to its new drug application for ARAKODA.
August 12, 2024 | 2:07 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
60 Degrees Pharmaceuticals shares are trading higher after the company granted the University of Kentucky a right of reference to its new drug application for ARAKODA.
The announcement of granting a right of reference to the University of Kentucky for ARAKODA's new drug application is a positive development, likely boosting investor confidence and driving the stock price higher.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100